AstraZeneca PLC AZN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 9:10 AM EST
48.42quote price arrow up+0.33 (+0.69%)
Volume
420,072
Close
48.09quote price arrow down-0.29 (-0.60%)
Volume
11,115,098
52 week range
36.15 - 64.94

...

Loading . . .

KEY STATS

  • Open48.46
  • Day High48.68
  • Day Low48.08
  • Prev Close48.09
  • 52 Week High64.94
  • 52 Week High Date07/20/20
  • 52 Week Low36.15
  • 52 Week Low Date03/16/20
  • Market Cap126.255B
  • Shares Out2.625B
  • 10 Day Average Volume10.53M
  • Dividend1.40
  • Dividend Yield2.91%
  • Beta0.56
  • 1 Year % Change9.79

RATIOS/PROFITABILITY

  • EPS (TTM)1.22
  • P/E (TTM)39.51
  • Fwd P/E (NTM)70.72
  • EBITDA (MRQ)7.505B
  • ROE (MRQ)22.23%
  • Revenue (MRQ)26.617B
  • Gross Margin (MRQ)80.02%
  • Net Margin (MRQ)11.81%
  • Debt To Equity (MRQ)130.46%

EVENTS

  • Earnings Date04/30/2021
  • Ex Div Date02/25/2021
  • Div Amount0.95
  • Split Date-
  • Split Factor-

QUOTE FINDER

Related Video

VIDEO3:2803:28
It's a critical time in the pandemic, says former acting CDC director

Profile

MORE
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of...
Leif Johansson
Non-Executive Chairman
Pascal Soriot
Chief Executive Officer
Marc Dunoyer
Chief Financial Officer
Ruud Dobber
Executive Vice President
Menelas Pangalos
Executive Vice President
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom